Edge Gravity By Ericsson

BioNTech US Inc, based in Cambridge, MA, is a pioneering global immunotherapy company that focuses on developing innovative treatments aimed at combatting cancer, infectious diseases, and other serious health conditions. With its origins in Mainz, Germany, the company leverages a robust international network and a strong commitment to research and development to advance next-generation immunotherapies. Driven by scientific rigor and operational excellence, BioNTech is dedicated to unlocking the full potential of the immune system and enhancing the health of individuals worldwide. The company continually expands its global manufacturing capabilities to ensure equitable access to its innovative therapies. Generated from the website

Scholar Rock, based in Cambridge, MA, is a biopharmaceutical company dedicated to revolutionizing therapeutic approaches through innovative science and a unique drug discovery platform. With a focus on protein growth factors, Scholar Rock aims to advance the standard of care for neuromuscular diseases and other conditions where growth factor-targeted drugs can make a significant impact. Through a decade of research and development, Scholar Rock has built a promising pipeline of product candidates targeting a range of serious diseases such as spinal muscular atrophy, oncology, anemia, and fibrosis. By shining new light on overlooked areas of medicine, the company is committed to discovering, developing, and delivering life-changing therapies that have the potential to transform patient outcomes.Generated from the website

Jounce Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies to enhance cancer immunotherapy. Through their research and development, they aim to utilize the body's immune system to combat cancer more effectively. Concentra Biosciences LLC operates under Jounce Therapeutics, contributing to their mission by helping to advance diverse biomedical innovations. Their efforts support breakthrough advancements in treating various malignancies and improving patient outcomes. Generated from the website